Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1163, pseudogene (RNU6-1163P) is a noncoding **human pseudogene** belonging to the family of U6 small nuclear RNAs, specifically catalogued as a processed RNA pseudogene. Unlike functional U6 snRNA, which plays a critical role in the spliceosome and mRNA splicing, RNU6-1163P is not known to be transcribed or participate in cellular biological functions. It was created through retrotransposition events and is used as a marker for retrotransposition dynamics in genomic studies[1][3][5][6]. Pseudogenes like RNU6-1163P generally do not produce functional RNA or protein, nor do they serve as direct molecular drug targets. There is no evidence for functional, diagnostic, or therapeutic relevance for RNU6-1163P specifically in the current literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1163, pseudogene (RNU6-1163P).